NewAmsterdam Pharma Company N.V

NAMS · Healthcare

$24.92

Markedsværdi: 2.91B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe NewAmsterdam Pharma Company N.V? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire3. sep. 2026, 20.01

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire2. sep. 2026, 15.03

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction

GlobeNewswire2. sep. 2026, 12.00

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September

Clinical Trials Arena1. sep. 2026, 17.47

EMA debuts NAM data sharing pilot amid animal testing divergence